Literature DB >> 6208355

The reticulocytic rat: a model for analysis of methotrexate polyglutamate dynamics in situ.

G R Krakower, B A Kamen.   

Abstract

The metabolism of the antifol methotrexate in rat erythrocytes in order to determine the basis for its persistence in this tissue was investigated. By using molecular sieve high-performance liquid chromatography and a methotrexate radioassay, we have detected methotrexate polyglutamates through the heptaglutamate in red cells of rats given a single i.p. injection of 10 mg/kg of methotrexate. Higher concentrations of methotrexate and its polyglutamates were found in blood from animals made reticulocytic with phenylhydrazine than in normal erythrocytes, lending credence to the hypothesis that red cell methotrexate polyglutamates arise from developing erythrocytes in the marrow. This was borne out in discrete populations of red cells and reticulocytes separated by density centrifugation through Percoll. Reticulocytes also were shown to have no significant gamma-glutamylcarboxypeptidase (conjugase) activity. We present the reticulocytic rat as an in vivo model for studying polyglutamate metabolism.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6208355

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  6 in total

1.  Methotrexate in erythrocytes of patients with psoriasis.

Authors:  H Schrøder; E K Foged
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

2.  Methotrexate kinetics in myeloid bone marrow cells and peripheral neutrophils.

Authors:  H Schrøder
Journal:  Cancer Chemother Pharmacol       Date:  1987       Impact factor: 3.333

3.  Methotrexate pharmacokinetics in age-fractionated erythrocytes.

Authors:  H Schrøder
Journal:  Cancer Chemother Pharmacol       Date:  1986       Impact factor: 3.333

4.  In vivo decline of methotrexate and methotrexate polyglutamates in age-fractionated erythrocytes.

Authors:  H Schrøder; K Fogh; T Herlin
Journal:  Cancer Chemother Pharmacol       Date:  1988       Impact factor: 3.333

5.  Methotrexate and its polyglutamate derivatives in erythrocytes during and after weekly low-dose oral methotrexate therapy of children with acute lymphoblastic leukemia.

Authors:  H Schrøder; K Fogh
Journal:  Cancer Chemother Pharmacol       Date:  1988       Impact factor: 3.333

6.  Pharmacokinetics of erythrocyte methotrexate in children with acute lymphoblastic leukemia during maintenance treatment.

Authors:  H Schrøder; N Clausen; E Ostergaard; T Pressler
Journal:  Cancer Chemother Pharmacol       Date:  1986       Impact factor: 3.333

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.